中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性胆汁性胆管炎合并系统性硬化病并发消化道出血1例报告

高卉 殷鑫 张传霞 温晓玉

引用本文:
Citation:

原发性胆汁性胆管炎合并系统性硬化病并发消化道出血1例报告

DOI: 10.3969/j.issn.1001-5256.2018.11.029
基金项目: 

国际科技合作重点项目计划(20150414016GH); 

详细信息
  • 中图分类号: R575.7;R593.2

Research funding: 

 

  • 摘要: <正>自身免疫性肝病(autoimmune liver diseases,AILD)是由自身免疫异常介导的炎症性疾病,以循环中出现自身抗体、血清Ig水平升高及肝组织学炎症改变为特点,主要包括自身免疫性肝炎、原发性胆汁性胆管炎(PBC)、原发性硬化性胆管炎、Ig G4相关硬化性胆管炎等[1]。若患者同时患有或者病程中的不同阶段出现2种自身免疫性肝病的临床、血清学、组织学特点,称为AILD重叠综合征[2],其发病机制目前尚未明确,不同

     

  • [1] MA X. The management of autoimmune liver diseases:From the consensus to the guideline[J]. Chin J Hepatol, 2016, 24 (1) :3-4. (in Chinese) 马雄.自身免疫性肝病的诊治:从共识到指南[J].中华肝脏病杂志, 2016, 24 (1) :3-4.
    [2] LI B, SHAO Q, NIU XX, et al. Clinical features and diagnosis of autoimmune hepatitis-primary billiary cirrhosis overlap syndrome[J]. J Clin Hepatol, 2014, 30 (5) :413-416. (in Chinese) 李冰, 邵清, 牛小霞, 等.自身免疫性肝炎-原发性胆汁性肝硬化重叠综合征的临床特点及诊断分析[J].临床肝胆病杂志, 2014, 30 (5) :413-416.
    [3] OZASLAN E, EFE C, GOKBULUT OZASLAN N. The diagnosis of antimitochondrail antibody-negative primary biliary cholangitis[J]. Clin Res Hepatol Gastroenterol, 2016, 40 (5) :553-561.
    [4] WANG JS, YAO DK. Value of autoantibodies in predicting autoimmune liver disease[J]. J Clin Hepatol, 2011, 27 (3) :333-336. (in Chinese) 王嘉森, 姚定康.自身抗体在自身免疫性肝病中的预测价值[J].临床肝胆病杂志, 2011, 27 (3) :333-336.
    [5] ASANO Y, JINNIN M, KAWAGUCHI Y, et al. Diagnostic criteria, severity classification and guidelines of systemic sclerosis[J]. J Dermatol, 2018, 45 (6) :633-691.
    [6] GUO ZJ, LI XP, SONG WY. Clinical analysis of 50 cases of systemic sclerosis[J]. Anhui Med Pharm J, 2010, 14 (7) :812-813. (in Chinese) 郭兆军, 李向培, 宋维亚.系统性硬化症50例临床分析[J].安徽医药, 2010, 14 (7) :812-813.
    [7] van den HOOGEN F, KHANNA D, FRANSEN J, et al. Classification criteria for systemic sclerosis:An ACR-EULAR collaborative initiative[J]. Arthritis Rheum, 2013, 65 (11) :2737-2747.
    [8] SJOGERN RW. Gastrointestinal features of scleroderma[J]. Curr Opin Rheumatol, 1996, 8 (6) :569-579.
    [9] WALKER UA, TYNDALL A, CZIRJAK L, et al. Geographi variation of disease manifestations in systemic sclerosis:A report from the EULAR Scleroderma Trials and Research (EUSTAR) group database[J]. Ann Rheum Dis, 2009, 68 (6) :856-862.
    [10] MURRAY-LYON IM, THOMPSON RP, ANSELL ID, et al.Scleroderma and primary biliary cirrhosis[J]. BMJ, 1970, 3 (5717) :258-259.
    [11] ASSASSI S, FRITZLER MJ, ARNETT FC, et al. Primary biliary cirrhosis (PBC) , PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients[J]. J Rheumatol, 2009, 36 (10) :2250-2256.
    [12] RIGAMONTI C, SHAND LM, FEUDJO M, et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis[J]. Gut, 2006, 55 (3) :388-394.
    [13] LIU JX. Clinical features and treatment methods of liver cirrhosis patients with non-variceal upper gastrointestinal bleeding[J/CD].Chin J Liver Dis:Electronic Edition, 2016, 8 (2) :86-89. (in Chinese) 刘吉祥.肝硬化非静脉曲张性上消化道出血的临床特征及治疗方法[J/CD].中国肝脏病杂志:电子版, 2016, 8 (2) :86-89.
    [14] Committee of Esophageal Varicosity, Society of Digestive Endoscopy of Chinese Medical Association. Tentative guidelines for endoscopic diagnosis and treatment of varicosity and variceal bleeding in digestive tract (2009) [J]. Chin J Dig Endosc, 2010, 27 (1) :1-4. (in Chinese) 中华医学会消化内镜学分会食管胃静脉曲张学组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案 (2009年) [J].中华消化内镜杂志, 2010, 27 (1) :1-4.
    [15] WANG Z, HAO CM. Systemic scleroderma with recurrent upper gastrointestinal bleeding:A report of 1 cases[J]. Med J Communicat, 2014, 28 (1) :96-97. (in Chinese) 王征, 郝成明.表现为反复上消化道出血的系统性硬皮病1例[J].交通医学, 2014, 28 (1) :96-97.
    [16] WU Q, HE XD, TAO LY, et al. Diagnosis and treatment of CREST syndrome complicated with upper gastrointestinal bleeding[J]. Chin J Dig Surg, 2011, 10 (2) :139-140. (in Chinese) 武峤, 何小东, 陶连元, 等. CREST综合征合并上消化道出血的诊断与治疗[J].中华消化外科杂志, 2011, 10 (2) :139-140.
    [17] ZUBER-JERGER I, MULLER A, KULLMANN F, et al. Gastrointestinal manifestation of systemic sclerosis-thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign[J]. Rheumatology (Oxford) , 2010, 49 (2) :368-372.
    [18] NADASHKEVICH O, DAVIS P, FRITZLER M, et al. A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis[J]. Clin Rheumatol, 2006, 25 (2) :205-212.
    [19] LI HY, YANG L, HE JJ, et al. Progress of gastrointestinal involvement in systemic sclerosis[J]. Chin J Gen Pract, 2017, 16 (9) :725-728. (in Chinese) 李红艳, 杨林, 何晶晶, 等.系统性硬化症消化道受累诊疗进展[J].中华全科医师杂志, 2017, 16 (9) :725-728.
    [20] NITIN KA, LEAH M, JOHN OC, et al. Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis[J]. Semin Arthritis Rheum, 2018.[Epub ahead of print]
  • 加载中
计量
  • 文章访问数:  1607
  • HTML全文浏览量:  8
  • PDF下载量:  311
  • 被引次数: 0
出版历程
  • 出版日期:  2018-11-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回